- Toral Gathani, senior clinical research fellow1 2,
- Ramsey Cutress, professor of breast surgery David Dodwell, senior clinical research fellow32 4,
- Kieran Horgan, consultant breast surgeon5,
- Cliona Kirwan, professor of surgical trials6 7,
- Hilary Stobart, independent patient advocate8,
- Sau Wan Kan, data analyst1,
- Gillian Reeves, professor of epidemiology1,
- Sian Sweetland, senior statistician1
- 1Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK
- 2Oxford University Hospitals NHS Foundation Trust, Oxford, UK
- 3Cancer Sciences, University of Southampton and University Hospitals Southampton, Southampton, UK
- 4Nuffield Department of Population Health, University of Oxford, Oxford, UK
- 5Department of Breast Surgery, St James’s Hospital, Leeds, UK
- 6Division of Cancer Sciences, School of Medical Sciences, University of Manchester, Manchester, UK
- 7Nightingale Breast Centre, Manchester University NHS Foundation Trust, Manchester, UK
- 8Independent Cancer Patients’ Voice, London, UK
- Correspondence to: T Gathani toral.gathani{at}ndph.ox.ac.uk
Breast cancer is the most common malignancy in women globally.1 Improvements in breast cancer survival over several decades are partly attributed to population based breast screening programmes and rapid access to specialist diagnostic services for patients with breast symptoms. These facilitate diagnosis at early stages and prompt access to treatment. Even delays as short as a month in diagnosis and starting treatment can be associated with poorer outcomes.234
Population based breast screening programmes have been the subject of much international comparison, investigation, and debate. However, less is known about the performance of healthcare services that assess women and men referred from primary care with symptoms that may indicate breast cancer, even though these services identify a large proportion of people with breast cancer. In England, six out of 10 people with breast cancer are diagnosed after referral with symptoms.5
Services for breast symptoms are under increasing pressure. Over five million people with breast symptoms have been referred for urgent or routine assessment over the past decade in England, making it the highest volume cancer referral service in the NHS.6 With such high overall volumes, small mismatches between capacity and demand rapidly lead to large numbers of patients waiting for assessment and may delay the diagnosis of breast cancer in some patients. In 2021-22, four out of 10 patients referred urgently or routinely waited longer than the recommended 14 days for assessment, the lowest performance for timely assessment among all cancers.7
The challenge of managing the volume of referrals has led to calls for a review of breast services, including the development and evaluation of safe …
"breast" - Google News
April 26, 2023 at 04:28PM
https://ift.tt/GV0h97O
Age and sex can predict cancer risk in people referred with breast symptoms - The BMJ
"breast" - Google News
https://ift.tt/EdsXJyk
https://ift.tt/GPEkOyU
Bagikan Berita Ini
0 Response to "Age and sex can predict cancer risk in people referred with breast symptoms - The BMJ"
Post a Comment